Intellia Therapeutics's total assets for Q3 2024 were $1.17B, a decrease of -1.53% from the previous quarter. NTLA total liabilities were $210.74M for the fiscal quarter, a -4.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.